Birchview Capital’s ContraFect CFRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CFRX
AG
Birchview Capital's CFRX Position: Q4 2022 in Review
Birchview Capital sold out of ContraFect (CFRX) in Q4 2022, closing a stake of 2,500 shares — an estimated $34K sold.
Birchview Capital first reported a position in CFRX in Q2 2015 and held it in 30 quarters. The position peaked at $2.38M in Q2 2018. 40 funds tracked by Wall St. Rank hold CFRX as of Q4 2022.
- Birchview Capital reported no remaining ContraFect position as of Q4 2022 after selling out during the quarter.
- Birchview Capital sold 2,500 ContraFect shares in Q4 2022, an estimated $34K.
- Birchview Capital first reported a position in ContraFect in Q2 2015 and held it in 30 quarters.
- Birchview Capital's ContraFect position peaked at $2.38M in Q2 2018.
- 40 funds tracked by Wall St. Rank held ContraFect as of Q4 2022.
Based on Birchview Capital's 13F filing for Q4 2022, filed 3 Feb 2023.